Used primarily in the pharmaceutical industry as a key intermediate in the synthesis of antipsychotic medications. It plays a critical role in the production of drugs targeting dopamine and serotonin receptors, particularly in the treatment of schizophrenia and other psychiatric disorders. Due to its fluorinated structure and piperidine moiety, it enhances blood-brain barrier penetration and receptor binding affinity, making it valuable in central nervous system drug development. Its derivatives are also explored for potential use in positron emission tomography (PET) imaging agents due to the presence of fluorine-18 labeling possibilities.